Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zichel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medizinische Klinik|May 1, 1970
[Clinical contribution to uterine sarcoma]R Zichel, P Hofmann
Archiv Fur Gynakologie|April 27, 1971
[Experimental studies with pregnant rabbits on the relation between acute utero-placental circulation disorders and intrauterine fetal death]K Jantzen, M Hölzl, J Niedersen, et al.
Clinical and Vaccine Immunology : CVI|April 2, 2010
Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression systemR Zichel, A Mimran, A Keren, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 15, 2014
Factor IX oligomerization underlies reduced activity upon disruption of physiological conditionsV L Simhadri, N Hamasaki-Katagiri, S C Tseng, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medizinische Klinik|May 1, 1970
[Clinical contribution to uterine sarcoma]R Zichel, P Hofmann
Archiv Fur Gynakologie|April 27, 1971
[Experimental studies with pregnant rabbits on the relation between acute utero-placental circulation disorders and intrauterine fetal death]K Jantzen, M Hölzl, J Niedersen, et al.
Clinical and Vaccine Immunology : CVI|April 2, 2010
Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression systemR Zichel, A Mimran, A Keren, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 15, 2014
Factor IX oligomerization underlies reduced activity upon disruption of physiological conditionsV L Simhadri, N Hamasaki-Katagiri, S C Tseng, et al.
Pageof 1